Recall substandard syrups, Maiden Pharma told

Solan, January 18 With five samples of the CSP cough syrup manufactured by the Baddi-based Maiden Pharmaceuticals being declared substandard by the national-level regulator last evening, the firm has been directed to furnish details about its stock and distribution....

Our Correspondent

Updated At : 12:18 PM Jan 19, 2023 IST

Solan, January 18

With five samples of the CSP cough syrup manufactured by the Baddi-based Maiden Pharmaceuticals being declared substandard by the national-level regulator last evening, the firm has been directed to furnish details about its stock and distribution.

“Maiden Pharmaceuticals has been directed to recall all cough syrups of five batches declared substandard at the earliest and provide information pertaining to their stock, sale and distribution,” said Manish Kapoor, Deputy Drugs Controller, Baddi.

There would be no compromise on the quality of manufactured drugs and the pharmaceutical firms would have to strictly comply with the laid down norms, he added.

To ensure quality manufacturing, Maiden Pharma would have to seek a re-audit from the drug authorities. It was ordered to stop manufacturing on November 2, 2022.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Suggested Articles